November 25th, 2019Pivotal’s QA & Compliance Director Francisco Calvo recently participated in Brussels in an interactive conference on GDPR Pivotal’s QA…
October 8th, 2019Pivotal has recently participated with a booth number 451 at the ESMO congress in Barcelona, which ended on Tuesday, October…
September 6th, 2019Pivotal, the Madrid-based, European-wide Clinical Research Organization (CRO), is participating with a booth at the forthcoming ESMO (European Society for…
July 3th, 2019Collaboration will allow patients in the EU and US to access previously inaccessible investigational cancer therapies for the first time…
May 27th, 2019The American Society of Clinical Oncology (ASCO) Annual Meeting will be held in Chicago, (USA) Pivotal, represented by members…
February 6th, 2019New collaboration aims to further accelerate the delivery of novel treatments for difficult-to-treat cancers Pivotal has enrolled the first…
October 26th, 2018ESMO 2019 annual congress will take place in Barcelona, from the 27th of September to 1st October On Tuesday,…
October 8th, 2018Pivotal and ESMO working on different levels to improve prevention, diagnosis, treatment, and palliative care of cancer patients through clinical…
September 10th, 2018New collaboration aims to further accelerate the delivery of investigational treatments for asthma Pivotal and Palobiofarma announced today a…
July 4th, 2018Collaboration will further assess novel investigational cancer treatments combined with standard chemotherapy PIVOTAL and APRO have announced today a…